CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 75 filers reported holding CYTEK BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $65,543,673 | -18.7% | 11,746,178 | -2.2% | 0.00% | -50.0% |
| Q1 2024 | $80,605,921 | -25.7% | 12,012,805 | +1.0% | 0.00% | 0.0% |
| Q4 2023 | $108,443,184 | +77.3% | 11,890,700 | +7.3% | 0.00% | 0.0% |
| Q3 2023 | $61,158,404 | -32.6% | 11,079,421 | +4.3% | 0.00% | 0.0% |
| Q2 2023 | $90,680,101 | +25.1% | 10,618,279 | +34.7% | 0.00% | 0.0% |
| Q1 2023 | $72,467,635 | -8.7% | 7,885,488 | +1.5% | 0.00% | 0.0% |
| Q4 2022 | $79,342,595 | -29.9% | 7,771,067 | +1.1% | 0.00% | -33.3% |
| Q3 2022 | $113,161,000 | +68.1% | 7,687,505 | +22.5% | 0.00% | +50.0% |
| Q2 2022 | $67,317,000 | -1.7% | 6,273,802 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $68,475,000 | +246.3% | 6,352,090 | +424.2% | 0.00% | – |
| Q4 2021 | $19,776,000 | -22.8% | 1,211,746 | +1.3% | 0.00% | -100.0% |
| Q3 2021 | $25,615,000 | – | 1,196,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |